Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09:36 | Aquaporin A/S: Aquaporin appoints Chief Executive Officer | 238 | PR Newswire | Company announcementNo. 09/2025
Inside information
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694
KONGENS LYNGBY, Denmark... ► Artikel lesen | |
21.05. | Aquaporin A/S: Aquaporin Q1 2025 Trading Statement - maintains full-year financial guidance for 2025 | 243 | PR Newswire | Company announcementNo. 08/2025
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694
KONGENS LYNGBY, Denmark , May 21, 2025 /PRNewswire/... ► Artikel lesen | |
15.05. | AQUAPORIN A/S: Aquaporin sells 500 CLEAR membranes to Chinese company CRZLO | 2 | Cision News | ||
08.05. | AQUAPORIN A/S: Aquaporin membranes to power projects in Chile and Mexico | 1 | Cision News | ||
AQUAPORIN Aktie jetzt für 0€ handeln | |||||
01.05. | AQUAPORIN A/S: Aquaporin secures pilot plant contract for Trinity College Dublin at the IBF National Bioeconomy Campus | 5 | Cision News | ||
24.04. | Business transacted at the Annual General Meeting of Aquaporin A/S | 2 | Cision News | ||
11.04. | Aquaporin A/S - Admittance to trading and official listing of new shares due to exercise of warrants | 134 | GlobeNewswire | The share capital of Aquaporin A/S has been increased. The admittance of trading and official listing of new shares will take effect as per 14 April 2025 in the ISIN below.
ISIN:
DK0061555109
Name:
Aquaporin
Volume... ► Artikel lesen | |
02.04. | AQUAPORIN A/S: Notice convening the Annual General Meeting 2025 | 2 | Cision News | ||
01.04. | AQUAPORIN A/S: Aquaporin announces resignation by the CEO | 3 | Cision News | ||
28.03. | AQUAPORIN A/S: Aquaporin achieves breakthrough in the wine industry | 2 | Cision News | ||
21.03. | AQUAPORIN A/S: Aquaporin Inside® technology to enhance water management in Liaocheng | 1 | Cision News | ||
20.03. | Aquaporin A/S: Aquaporin announces full-year 2024 results | 480 | PR Newswire | Company announcementNo. 03/2025
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.com Company registration no.: DK28315694
KONGENS LYNGBY, Denmark, March 20, 2025 /PRNewswire/... ► Artikel lesen | |
20.03. | Aquaporin A/S: Aquaporin announces guidance for 2025 | 90 | GlobeNewswire (Europe) | Company announcement
No. 02/2025
Inside information
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Kongens Lyngby, Denmark, March 20, 2025 -... ► Artikel lesen | |
12.03. | AQUAPORIN A/S: Aquaporin to host full-year 2024 results webcast on March 20 | 1 | Cision News | ||
26.02. | Aquaporin A/S: Aquaporin improves EBIT and specifies revenue guidance for 2024 | 109 | GlobeNewswire (Europe) | Company announcement
No. 01/2025
Inside information
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Kongens Lyngby, Denmark, February 26, 2025... ► Artikel lesen | |
14.11.24 | Aquaporin A/S: Aquaporin Q3 2024 Trading Statement | 527 | GlobeNewswire (Europe) | Company announcement
No. 19/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Copenhagen, Denmark, November 14, 2024 - Aquaporin A/S (ticker:... ► Artikel lesen | |
23.08.24 | Aquaporin A/S: Aquaporin enters strategic partnership with industry leader Brenntag | 766 | PR Newswire | Company announcementNo. 17/2024
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694
KONGENS LYNGBY, Denmark, Aug. 23, 2024 /PRNewswire/... ► Artikel lesen | |
22.08.24 | Aquaporin A/S: Aquaporin announces results for first half 2024 with revenue increase of 44% | 258 | GlobeNewswire (Europe) | Company announcement
No. 16/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Kongens Lyngby, Denmark, August 22, 2024 - Aquaporin A/S... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EVOTEC | 7,488 | +0,65 % | Bayer, Evotec, HelloFresh, Rheinmetall, SFC Energy, thyssenkrupp nucera - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
CUREVAC | 4,630 | +29,84 % | ROUNDUP: Deutscher Pharmadeal - Biontech greift nach Curevac | MAINZ (dpa-AFX) - Das Mainzer Pharmaunternehmen Biontech will den Rivalen Curevac aus Tübingen übernehmen. Beabsichtigt sei, alle Aktien von Curevac zu erwerben, teilte Biontech am Donnerstag mit.... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 46,760 | 0,00 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN | - im Falle einer Marktzulassung wäre Mirdametinib die erste und einzige Behandlung in der Europäischen Union für Erwachsene und Kinder mit NF1-PN -
- die Entscheidung der Europäischen Kommission... ► Artikel lesen | |
BIONTECH | 91,75 | -0,11 % | BioNTech: Rücksetzer nach Kurssprung - und nun? | Die Aktie von BioNTech hat nach dem Deal mit Bristo-Myers Squibb zu Wochenbeginn deutlich zulegen können. Nun kam es zu ersten Gewinnmitnahmen. DER AKTIONÄR wirft noch einmal einen genauen Blick auf... ► Artikel lesen | |
EDGEWISE THERAPEUTICS | 15,750 | 0,00 % | RBC Capital behält Outperform-Rating für Edgewise Therapeutics-Aktie bei | ||
MOONLAKE IMMUNOTHERAPEUTICS | 44,170 | 0,00 % | MoonLake Immunotherapeutics - 8-K, Current Report | ||
RECURSION PHARMACEUTICALS | 5,400 | 0,00 % | Insmed surges on lung drug data; Recursion cuts staff | ||
QIAGEN | 40,745 | -0,04 % | Biotech Report: Qiagen und Biontech wenig bewegt, US-Sektor fest | (shareribs.com) Frankfurt / New York 06.06.2025 - Biotech-Werte zeigten sich im deutschen Handel durchwachsen. Biontech und Qiagen korrigierten leicht. An der Wall Street legte der Sektor hingegen deutlich... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 19,600 | 0,00 % | Why Summit Therapeutics Stock Tanked Today | ||
ADMA BIOLOGICS | 21,850 | 0,00 % | ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold? | ||
ENLIVEN THERAPEUTICS | 19,605 | 0,00 % | Enliven Therapeutics, Inc.: Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update | Updated data from the Phase 1 ENABLE clinical trial of ELVN-001 in CML to be presented at the EHA 2025 Congress in June
EHA abstract reported cumulative MMR rate... ► Artikel lesen | |
AVIDITY BIOSCIENCES | 31,990 | 0,00 % | Avidity Biosciences, Inc.: Avidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD Participants | -- Unprecedented data from FORTITUDE dose escalation cohorts for del-brax treated participants, compared to placebo, demonstrate improvement in function, strength and PROs as well as rapid... ► Artikel lesen | |
PHATHOM PHARMACEUTICALS | 9,060 | 0,00 % | Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032 | FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom's Citizen Petition... ► Artikel lesen | |
APOGEE THERAPEUTICS | 42,460 | 0,00 % | Apogee Therapeutics stock maintains buy rating ahead of key trial data | ||
ARCUTIS BIOTHERAPEUTICS | 13,720 | 0,00 % | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen |